Neo-adjuvant cisplatinum in locally advanced urothelial bladder cancer: a prospective randomized study of the group CUETO.
Martinez-Piñeiro
J A
JA
Urological Service, Hospital La Paz, Madrid.
Jimenez Leon
J
J
Gonzalez Martin
M
M
Arocena Lanz
F
F
Ramos Roncero
C
C
Flores
N
N
Portillo
J A
JA
Escudero
A
A
Jimenez Cruz
F
F
Isorna
S
S
D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary; D002945:Cisplatin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology / Q000517:prevention & control; D009367:Neoplasm Staging; D011446:Prospective Studies; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology
D002945:Cisplatin